Investment Criteria
The Go Red for Women Venture Fund is seeking promising companies at the Series A or B stages that are using evidence-based research to improve women鈥檚 cardiovascular and brain health.
In general, we look for companies that demonstrate:
- market demand for their product or service
- clarity around product-market fit
- current sales traction or clear path to market launch
- superior management teams in place
- solutions to women鈥檚 health needs outside the field of reproductive medicine and in categories that directly or indirectly improve heart and/or brain health
Think we’re a match for your company?
We dig deep: Is there a management team with the right know-how in place? Is the science solid? Has the company thoughtfully addressed regulatory, reimbursement and market adoption issues? Is the team steeped in a real understanding of women’s health needs and purpose-built design? Does the product or service help align clinical and financial incentives in the health care system? Is the business model realistic? Is the company capital-efficient?
Our in-depth vetting process is key to identifying the greatest opportunities for health impact and financial returns.
Frequently Asked Questions
The Go Red for Women Venture Fund invests across a spectrum of cardiovascular, brain and related health conditions that affect women exclusively, differently or disproportionately.
These conditions include but are not limited to:
- Heart disease (e.g., hypertension, congestive heart failure, atrial fibrillation)
- Diabetes, metabolic disease and kidney disease
- Stroke
- Sleep
- Menopause
- Pre-eclampsia, PCOS, gynecological diseases
- Mental health
- Dementia, Alzheimer鈥檚 disease
- Autoimmune disorders
- Gastrointestinal disorders
- Other categories that have a bearing on women鈥檚 heart and brain health
No, we do not. We’re not a fit for organizations whose products or services are primarily focused on fertility, healthy pregnancy, period tracking or birth control.
We will consider gynecological conditions that directly impact heart and brain health.
No, the Go Red for Women Venture Fund does not invest in companies focused on new drug development. Our investment focus spans health services, digital health and health IT, medical devices and diagnostics.
Health services, digital health and health IT, medical devices and diagnostics.
We invest at the Series A or Series B stages. We have some flexibility to invest in earlier stage companies, but it is limited to those that benefited from research funded all or in part by the 番茄视频.
A percentage of funding is reserved to make seed investments in companies that benefited from research funded all or in part by the 番茄视频.
Yes, we will lead, co-lead or join other investor-led syndicates. These decisions are made on a deal-by-deal basis.
In general, we invest $1 million-$3 million initially and up to $7 million in any one company over multiple rounds, based on need and opportunity. Note that these are ranges and subject to change.
We like to be actively engaged to help the companies we fund reach and sustain commercial success. We鈥檙e here to support, advise and connect. To further accelerate growth, we connect our portfolio companies to the Association’s vast clinical resources including training programs, data and registries, clinical trial capacity and a broad network of women’s health experts across science and industry.
While we can take board seats, this is determined on a deal-by-deal basis.
No, but we strongly prefer companies that recognize the importance of diverse leadership, women-centered design and the factors that inform go-to-market strategies for women. There has been ample research to show that teams that include women and diverse team members achieve better financial outcomes.